Paul McEwan is an accomplished angel investor at Life Science Angels since January 2019. Prior experience includes serving as Vice President and Lifecycle Leader for Sample Preparation at Roche from 2016 to December 2018. Paul co-founded Kapa Biosystems, Agencourt Personal Genomics, and Agencourt Bioscience, where Paul held positions including Chief Scientific Officer and co-founder from 2000 to 2016. Paul holds a degree from Emory University, completed between 1992 and 1996.
Links